MK0524 Seasonal Allergic Rhinitis Study (0524-005)(COMPLETED)

Seasonal Allergies Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00533208
• Other study ID #: 0524-005
• Secondary ID: 2007_616
• Status: Completed
• Phase: Phase 2
• First received: September 19, 2007
• Last updated: December 21, 2015
• Start date: July 2003
• Est. completion date: October 2003

Study information

• Verified date: December 2015
• Source: Merck Sharp & Dohme Corp.
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Food and Drug Administration
• Study type: Interventional

Clinical Trial Summary

To assess the efficacy of MK0524 on seasonal allergies.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 766
• Est. completion date: October 2003
• Est. primary completion date: October 2003
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

• Person has had at least 2 years of seasonal allergies

• Person has had a positive skin test to at least 1 of the allergens of the season

• Person is a non-smoker

Exclusion Criteria:

• Person has been hospitalized within the last 4 weeks

• Person is a female who has had a baby within the last 8 weeks or is still breast-feeding

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Rhinitis, Allergic, Seasonal
• Seasonal Allergies

Intervention

Drug:
• MK0524

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Merck Sharp & Dohme Corp.